Sun Pharma gets OAI classification

New Delhi: Sun Pharma on Thursday said the US health regulator has classified its Baska facility in Gujarat under Official Action Indicated (OAI) category following an inspection. The US Food and Drug Administration (USFDA) conducted the inspection at the plant from September 8 to September 19, 2025. The USFDA has subsequently determined that the inspection classification status of this facility is Official Action Indicated (OAI), the Mumbai-based drug major said in a regulatory filing. As per the USFDA, OAI implies that the regulator may withhold approval of any pending product applications or supplements filed from such facility.